Latest Competition News

Cannindah Resources Limited has had its trading suspension lifted immediately following the release of a capital raising announcement, signaling renewed market activity.

Cannindah Resources announces the resignation of Managing Director Tom Pickett and appoints Cam Switzer as Interim CEO, signaling a new phase for the Mt Cannindah copper and gold project.

WAM Income Maximiser Limited has reported a profitable first half since its April 2025 IPO, declaring its inaugural fully franked monthly dividend and setting guidance for dividend growth. The company’s diversified portfolio of ASX300 equities and investment grade corporate debt has delivered promising returns, underpinning its income and capital growth objectives.

INOVIQ Limited reported a $6.9 million net loss for FY25 while making significant strides in its exosome-based cancer diagnostics and therapeutics pipeline, including a breakthrough ovarian cancer screening test and promising CAR-exosome therapy results.

RLF AgTech Ltd has secured $4.5 million through a discounted share placement to support its strategic growth initiatives following a robust 74% revenue increase in FY2025. The company is advancing its Australian relaunch, expanding manufacturing, and entering new Asian markets.

RLF AgTech has secured a national supply agreement with Nutrien Ag Solutions, granting access to over 700 rural retail outlets across Australia. This partnership aims to boost RLF’s domestic presence and support sustainable farming practices.

Carbonxt Group Limited has announced a fully underwritten non-renounceable entitlement offer of Loyalty Options to eligible shareholders, aiming to raise approximately $697,772 to support its new Activated Carbon manufacturing facility in Kentucky. The offer provides shareholders with one Loyalty Option for every six shares held, exercisable at $0.07 within three years.

NOVONIX Limited reports progress scaling its Chattanooga synthetic graphite plant, secures major funding, and benefits from U.S. tariffs on Chinese imports, while narrowing its half-year loss.

LTR Pharma has announced that its erectile dysfunction treatment SPONTAN now boasts an 18-month shelf life, surpassing commercial standards and paving the way for international market growth.

Accent Group reported a modest 0.8% increase in FY2025 total sales to $1.62 billion, while profits dipped slightly. The company is advancing its store expansion and brand portfolio, targeting strong EBIT growth in FY26 despite startup costs.

Accent Group Limited reported a modest revenue increase but a 3.1% decline in net profit for FY25 amid a tough retail environment. The company announced a strategic partnership with Frasers Group to launch Sports Direct in Australia and New Zealand, signaling a new growth avenue.

Cynata Therapeutics has entered a five-year At-the-Market Subscription Agreement with Acuity Capital, enabling access to up to $7.5 million in standby equity capital with full discretion over timing and pricing.